Spike Postdoctoral Research Papers on International Frontier Journals
Release time:
2022-06-01
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat , A hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease was published in the internationally renowned academic journal" Frontiers in Pharmacology . This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
Alcoholic liver disease is one of the main types of liver disease in the world. Its pathogenesis includes the initial alcoholic fatty liver, which further evolves into alcoholic steatohepatitis, and even liver fibrosis and cirrhosis. It may deteriorate into liver cancer, and the pathogenesis is more complex, which has always been a hot topic in academic research. Previous academic research on alcoholic liver disease mainly focused on lipid metabolism disorders, alcohol-induced inflammatory infiltration, oxidative stress in liver cells, and intestinal microbial disorders. The research results of Yang Xiaoxiao and others focused on the new role of the chronic kidney disease anemia treatment drug roxaldostat in alcoholic liver disease. The therapeutic effect of roxaldostat was explored by constructing acute and chronic alcoholic liver disease models, and combined with cell experiments to verify the therapeutic effect. The results show that alcohol can cause lipid metabolism disorders, and also cause inflammation, oxidative stress and other adverse effects in the liver. Roxastat increases fatty acid oxidation by inhibiting the expression of lipid synthesis genes SREBP1c , ChREBP , FASN , ACC1 , DGAT1 , and promoting PPAR ; roxalustat can also reduce the accumulation of macrophages and the release of proinflammatory cytokines to improve the inflammatory process; roxalustat reduces the expression of CYP2E1 and promotes superoxide dismutase SOD1 , which can alleviate the oxidative stress caused by alcohol. The above studies show that roxalustat can be used as a potential treatment for alcoholic liver disease.
The research was supported by the China Postdoctoral Science Foundation and the Zhejiang Provincial Postdoctoral Program. Gao Yongyao and Yang Daigang, graduate students of Hefei University of Technology, are the co-first authors, and Yang Xiaoxiao, associate researcher, is the corresponding author.
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page